Decanoylcarnitine Improves Liver Mitochondrial Dysfunction in Hepatitis B Virus Infection by Enhancing Fatty Acid β-Oxidation - Takeaways - MDSpire

Decanoylcarnitine Improves Liver Mitochondrial Dysfunction in Hepatitis B Virus Infection by Enhancing Fatty Acid β-Oxidation

  • By

  • Ye Sun

  • Qingling Chen

  • Yuxiao Liu

  • Mengfan Jiao

  • Zixing Dai

  • Xiaoxue Hou

  • Rui Liu

  • Yuwen Li

  • Chuanlong Zhu

  • January 8, 2025

  • 0 min

Share

  • 1

    Decanoylcarnitine supplementation enhances fatty acid β-oxidation and mitigates mitochondrial dysfunction in liver cells infected with hepatitis B virus.

  • 2

    HBV infection leads to impaired fatty acid metabolism and mitochondrial dysfunction, contributing to liver disease progression.

  • 3

    CPT1A overexpression improves mitochondrial function in hepatocytes, suggesting a potential therapeutic target.

  • 4

    Decanoylcarnitine activates the PPAR signaling pathway, particularly PPARα, to restore mitochondrial function.

  • 5

    This study highlights the therapeutic potential of decanoylcarnitine for treating HBV-related mitochondrial dysfunction.

Original Source(s)

Decanoylcarnitine Improves Liver Mitochondrial Dysfunction in Hepatitis B Virus Infection by Enhancing Fatty Acid β-Oxidation

  • by Ye Sun, Qingling Chen, Yuxiao Liu, Mengfan Jiao, Zixing Dai, Xiaoxue Hou, Rui Liu, Yuwen Li, Chuanlong Zhu

  • January 8, 2025

Related Content

Graft weight integration in the early allograft dysfunction formula improves the prediction of early graft loss after liver transplantation

Female Sex is Protective Against MASLD With Clinically Significant Fibrosis in a Large Cross-sectional Cohort of Persons With HIV

Optimizing healthcare resources in pyogenic liver abscess: a dual-threshold HDL-CRP model for predicting hospitalization duration across multi-cohorts